IDEAYA Biosciences, Inc. Common Stock

IDYANASDAQ • USD
32.19 USD
↗ 0.36 (1.13%)🟢PRE MARKET (AS OF 04:04 AM EST)
🟢Market: OPEN

IDYA is currently priced at $32.19. The technical outlook is "Neutral" and the fundamental picture shows "Sell". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, IDYA trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Nov 13, 2026.

Open?$32.19
High?$32.19
Low?$32.19
Prev. Close?$31.83
Volume?1.0K
Avg. Volume?972.3K
VWAP?$32.19
Rel. Volume?0.00x
Bid / Ask
Bid?$26.85 × 100
Ask?$35.99 × 100
Spread?$9.14
Midpoint?$31.42
Valuation & Ratios
Market Cap?3.1B
Shares Out?96.7M
Float?87.1M
Float %?99.1%
P/E Ratio?N/A
P/B Ratio?2.82
EPS?-$4.34
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
Employees
145
Market Cap
3.1B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2019-05-23
Address
5000 SHORELINE CT, SUITE 300
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-443-6209
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
23
Short Sent.?
59
Piotroski F-Score?0/9Weak
Altman Z-Score?13.20Safe
Confidence?55%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?9.46%Elevated
Short Interest?8.2M
Days to Cover?8.9
Free Float87.1M
Avg Daily Volume928.5K
Settlement Date2026-10-30
Financial Health
Current Ratio?9.04Strong
Quick Ratio?9.04Strong
Cash Ratio?2.71Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
59
2.82CHEAP▾
P/S?
Peers
100
S&P
3
84.24HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-6.1CHEAP▾
EV/Sales?
Peers
100
S&P
3
77.09HIGH▾
Returns & Efficiency
ROE?
S&P
3
-38.5%WEAK▾
ROA?
S&P
3
-34.5%WEAK▾
Cash Flow & Enterprise
FCF?$-349797000
Enterprise Value?$2.8B
Fundamentals ratios updated end of day